3rd TRT Bellwether Trial to Begin on November 6, 2017
3rd TRT Bellwether Trial to Begin on November 6, 2017
Introduction
The third Testosterone Replacement Therapy bellwether lawsuit is scheduled to go before the jury on November 6 with Auxilium Pharmaceuticals as the defendant for their testosterone based Testim gel. The second Auxilium trial is set for April 9, 2018. Thousands of men have filed lawsuits against Testim gel maker, claiming failure to adequately warn about the potentially life-threatening injuries like heart attacks, stroke, pulmonary embolism, deep vein thrombosis and other blood clots, and death. The company had promoted Testim gel aggressively for the treatment of "Low T" symptoms. The gel works as a reservoir of testosterone that sticks to the skin and delivers the drug through the skin.
Comments
Latest News
Walgreens Settles Federal Opioid Case for $300 Million
Categories: Opioids
Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The U.S. Department of Justice announced on Monday…
Study: Opioid Use in Pregnancy May Shrink Newborn Brains
Categories: Opioids
New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…
Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting
Categories: Opioids
The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…